| Address: | 8 Pickett St, Marblehead, MA 01945, USA |
|---|---|
| Postal code: | 01945 |
| Phone: | (617) 638-8082 |
| Website: | http://www.bumc.bu.edu/anatneuro/our-people/faculty/killiany/ |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Ronald J. Killiany, PHD, use the form below and your opinion, advice or comment will appear in this space.
Dr. Ronald J. Killiany PhD is a male clinical psychologist in Marblehead, MA. The procedure that Dr. Killiany most frequently performs is Psychiatric Evaluation.
RONALD J KILLIANY, PhD - NPI #1699755645 Clinical Neuropsychologist. Profile for Dr RONALD J KILLIANY in MARBLEHEAD, MA.. A clinical psychologist who applies principles of assessment and intervention based upon the scientific study of human behavior as it relates to normal and abnormal functioning of the central nervous system.
Ronald J. Killiany, PhD Associate Professor, Environmental Health (617) 638-8082 killiany@bu.edu. Talbot. View full profile at BUMC. Biography
Therapist Ronald J. Killiany at Marblehead, Massachusetts specialized in Clinical Neuropsychologist. Check client reviews or rate Dr. Ronald Killiany.
Ronald J. Killiany, PhD Associate Professor, Anatomy & Neurobiology. 617.638.8082. killiany@bu.edu. 700 Albany St Ctr for Adv Biomed Res. View full profile at BUMC.
Mild cognitive impairment (MCI) represents a transitional state between normal aging and Alzheimer's disease (AD). Our goal was to determine if specific temporoparietal regions can predict the time to progress from MCI to AD. MRI scans from 129 individuals with MCI were analyzed to identify the ...
Ronald J. Killiany, PhD1,5,6,9 1 Department of Anatomy and Neurobiology, Boston University School of Medicine, USA 2 Department of Biostatistics, Boston University School of Public Health, USA 3 Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, USA
INTRODUCTION. Individuals classified with mild cognitive impairment (MCI) experience memory loss to a greater extent than expected for age and progress to a diagnosis of Alzheimer's disease (AD) at a faster rate than controls. 1 It has been hypothesized that MCI represents a transitional phase between normal function and AD 2 for many individuals.